Embolic Agents — a practical guide for vascular trainees
Coils, plugs, particles and liquid embolics: understand selection, sizing, safe handling and troubleshooting. A practical guide for vascular trainees.
Written August 21, 2026 · Mr Razhan K Ali
AT A GLANCE
Embolic agents deliberately obstruct blood flow. Choose the level of occlusion first: a defined vessel, an aneurysm's inflow and outflow, or a distal vascular bed. Then establish which normal circulation must remain patent.[1–3]
Coils and plugs usually provide focal mechanical occlusion. Particles travel into a distal vascular bed. Liquid embolics can penetrate and solidify within vessels or an abnormal vascular network. These roles overlap, and combinations may be appropriate.[1,2,4,7]
DESIGN & FUNCTION
A coil is a length of embolisation wire that forms loops after leaving its catheter. It occupies space and provides a scaffold for thrombosis; fibres on some coils increase thrombogenicity. A mesh plug expands within the vessel and reduces flow through its structure while thrombosis develops.[2,5,6]
Particles are discrete pieces carried forwards by blood flow until they lodge. Liquids are delivered as a fluid and form a solid or cohesive cast within the target circulation. This explains why a device fixed at one point cannot be assumed to treat an entire distal abnormal network.[1,4,7]
PROPERTIES & BEHAVIOUR
Where it stops matters more than what it is called
A correctly placed proximal coil can still leave a lesion perfused through collaterals. Conversely, an agent that penetrates farther may infarct normal tissue sharing the same blood supply. Map the target, alternative inflow and vulnerable branches before choosing the agent.[1,3]
Implantation and occlusion are different events
Conventional fibre coils and mesh plugs rely substantially on thrombus formation, so occlusion may be delayed when coagulation is impaired. By contrast, cyanoacrylate polymerisation and polymer precipitation form an embolic cast irrespective of coagulation status.[2,4,5]
This may influence agent selection during active bleeding or coagulopathy, but embolic choice does not replace haemorrhage resuscitation or correction of coagulopathy.[4]
Permanent material does not guarantee durable exclusion: residual channels, recanalisation or collateral filling can sustain the lesion. Completion imaging and condition-specific surveillance remain necessary.[1,2,8]
TYPES & EXAMPLES
| Agent | Mechanism and useful role | Main limitation |
|---|---|---|
| Pushable coil, e.g. Nester | Thrombogenic loops for focal vessel occlusion or packing. Delivered through the specified catheter using the prescribed wire/pusher system.[2,6] | No controlled detachment step; accurate positioning and stable support are essential.[2,6] |
| Detachable coil, e.g. Retracta | Position can be assessed and, where permitted, adjusted before detachment; useful when placement is especially critical.[6] | Repositioning ends at detachment and remains subject to the device's resistance limits.[6] |
| Vascular plug, e.g. Amplatzer Vascular Plug II | Expanding mesh for a suitable vessel segment; may simplify occlusion of a larger vessel.[2,5] | Requires appropriate diameter, adequate deployment length and a compatible delivery catheter/sheath; occlusion is not necessarily immediate.[5] |
| NBCA glue | Adhesive cyanoacrylate that polymerises on contact with ionic fluid; useful for selected distal targets and vascular networks.[1,4] | Non-target passage, reflux and catheter adhesion; ethiodized-oil dilution alters polymerisation and penetration.[1,4] |
| EVOH liquid | Ethylene-vinyl alcohol copolymer precipitates as DMSO disperses, producing a cohesive non-adhesive cast.[4] | Requires a DMSO-compatible delivery system; non-adhesive does not mean that catheter entrapment is impossible.[4] |
| Permanent particles / microspheres | Distal-bed embolisation; calibrated microspheres provide specified size ranges. Embosphere is a non-resorbable tris-acryl polymer microsphere impregnated with porcine gelatin.[7] | Distribution depends on size, flow and anatomy; shunting may carry particles beyond the intended bed.[7] |
| Resorbable gelatin | A particulate option when a resorbable material is appropriate; distinct from permanent microspheres.[10] | Resorbability does not remove the risks of non-target embolisation or ischaemic injury.[10] |
CHOOSING THE TOOL
1. Decide whether the parent vessel can be sacrificed
Assess the territory supplied and its collateral reserve. If essential flow must be preserved, consider a strategy that excludes the lesion while maintaining the artery, such as an anatomically suitable covered stent; simply choosing a smaller embolic agent does not solve the problem.[1,3]
For iliac aneurysm repair, ESVS recommends preserving flow to at least one internal iliac artery. If internal iliac embolisation is necessary during common iliac aneurysm repair, proximal mainstem occlusion is recommended when feasible to preserve distal pelvic collaterals.[8]
2. Match the agent to the target
- A defined vessel: coils offer flexible selective placement. A plug is attractive when the vessel can accommodate its deployed length and delivery system.[2,5]
- A lesion with inflow and outflow: consider isolation on both sides if collateral back-filling would otherwise sustain it. Secure the distal side before closing the proximal route needed to reach it.[1,3]
- A distal vascular bed: particles are useful when the intended territory can be selectively reached and dangerous communications have been excluded.[7]
- An arteriovenous malformation: target the nidus—the abnormal shunting network. Indiscriminate proximal feeder occlusion may leave the nidus patent, recruit collaterals and prevent later access. Direct fistulas and selected venous/outflow compartments may instead require mechanical occlusion with coils or plugs as part of an anatomy-specific strategy.[1]
3. Check what could carry the agent elsewhere
Review flow, reflux routes and arteriovenous communications. A large or high-flow shunt changes the plan; it is not a reason simply to inject more slowly. Embosphere specifically contraindicates high-flow AV shunts and shunts with a diameter greater than the selected microspheres.[7]
Type II endoleak illustrates why the indication comes before the agent. Coils and liquids are used, but the presence of a type II endoleak alone does not establish a need for embolisation. ESVS 2024 says secondary intervention should only be considered with sac growth ≥10 mm compared with baseline or the smallest follow-up diameter, using the same modality and measurement method, after excluding type I/III leaks (Class IIa, Level C). NICE advises considering intervention when there is AAA sac expansion but gives no numerical threshold.[8,9]
SIZING & COMPATIBILITY
For coils, separate three dimensions: delivery-platform calibre, formed loop diameter and extended coil length. The loop must fit the target and resist migration; length determines how much material is deployed. Check the exact coil–catheter combination rather than relying on a French-size label.[2,6]
For plugs, check diameter and deployed length. As one product-specific example, the AVP II IFU specifies a diameter approximately 30–50% larger than the vessel at the occlusion site. Confirm sufficient available length without obstructing an important branch. Do not transfer that percentage to another plug or to a coil.[5]
For particles, size in micrometres describes a range, not a guaranteed landing point. Smaller particles may penetrate farther and increase distal tissue injury. Select the particle for the intended territory, shunts and permitted catheter; size alone does not make an unsafe vascular communication safe.[7]
For liquids, chemistry and delivery-system compatibility are as important as lumen size. For transcatheter delivery, use an appropriate microcatheter rather than a standard diagnostic catheter: proximal positioning and dead space impair control. Direct percutaneous puncture is an alternative route for selected lesions.[1,4,8]
Cyanoacrylate delivery systems require an anion-free flush—typically 5–10% dextrose—to avoid premature polymerisation. EVOH requires a DMSO-compatible microcatheter and product-specific DMSO preparation. Follow the exact agent instructions; there is no universal glue dilution or injection rate.[4]
HANDLING PRINCIPLES
- Define the endpoint before deployment. Identify the target vessel or compartment, branches to preserve, collateral routes and desired angiographic result.[1–3]
- Build a stable delivery platform. A supported selective catheter or coaxial microcatheter limits recoil. Passing a coil and delivery wire changes system stiffness and may displace the catheter tip.[2,3]
- Preserve access in the planned sequence. When isolating a bleeding gastroduodenal artery, for example, distal occlusion treats collateral “back-door” filling before proximal “front-door” closure.[3]
- Observe delivery continuously. Confirm position before detachment; with injected agents, monitor distribution and changing flow. Stop for reflux towards a non-target branch or unexplained resistance.[4–7]
- Reassess the result. Confirm target occlusion and preservation of required branches; look for residual or collateral filling before removing useful access.[1–3,5]
PITFALLS & TROUBLESHOOTING
| Problem | Response |
|---|---|
| Catheter backs out during coil delivery | Stop advancing. Reassess tip position, support and coil–catheter fit before continuing; a coil released from the wrong position may obstruct an essential branch.[2,6] |
| Coil or plug position is unsatisfactory | Before detachment, use only the device-permitted repositioning or recapture method. After detachment, do not assume that the delivery system can recapture the device; reassess position and flow and use a device- and anatomy-specific rescue strategy if required.[5,6] |
| Resistance during delivery or injection | Stop. Check position, delivery path and component compatibility. Follow the exact IFU for removal or replacement; additional force risks device or vessel damage.[5–7] |
| Flow persists after deployment | Allow the appropriate device-specific assessment interval and repeat imaging. Distinguish residual flow through the construct from an uncovered channel or collateral inflow before adding further material; consider coagulation status where relevant.[1,2,3,5] |
| Pain, fever or clinical deterioration afterwards | Post-embolisation syndrome can occur, but severe or progressive symptoms or haemodynamic instability should prompt assessment for significant tissue infarction, abscess or persistent bleeding.[1] |
REMEMBER
- Choose the intended level of occlusion and the circulation to preserve first.[1,3]
- Coils and plugs usually provide focal mechanical occlusion; particles and liquids can penetrate beyond the catheter tip according to size, flow and agent behaviour.[1,2,4,7]
- Collateral back-filling can defeat a technically satisfactory proximal occlusion.[1,3]
- Sizing, preparation and repositioning are product-specific.[4–7]
- Confirm the clinical and angiographic result; implantation alone is not success.[1,2,8]
References
- Sidawy AN, Perler BA, editors. Rutherford’s Vascular Surgery and Endovascular Therapy. 10th ed. Elsevier; 2023.
- Schneider PA. Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery. 4th ed. CRC Press; 2019 (copyright 2020). DOI.
- Dalman RL, editor. Operative Techniques in Vascular Surgery. 1st ed. Wolters Kluwer; 2015.
- Giurazza F, et al. CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice. Cardiovasc Intervent Radiol. Published 23 September 2026. Standards of practice.
- Abbott. Amplatzer Vascular Plug II: Instructions for Use. ARTMT600149480_B. IFU.
- Cook Medical. Nester Embolization Coils, T_CE_NEC_REV4, and Retracta Detachable Embolization Coil, T_MWCER_REV6: instructions for use. Nester IFU; Retracta IFU.
- Merit Medical. Embosphere Microspheres: Instructions for Use. European vial version, 730034006EN_002, 23 September 2025. IFU.
- Wanhainen A, et al. ESVS 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2024;67(2):192–331. Recommendations 107, 137 and 138. DOI.
- NICE. Abdominal aortic aneurysm: diagnosis and management. NG156. Recommendation 1.8.2. Recommendations.
- Merit Medical. EmboCube Embolization Gelatin: Instructions for Use. 703090003_001. IFU.